Skip to main content
Search
Newsletters
Watchlist
Home
Watchlist
For You
Canada
World
Business
Investing
Personal Finance
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Latest in
TSX Today:
TLRY-T
-5.86%
WEED-T
+4.74%
HBM-T
+2.58%
BITF-T
+1.65%
BTO-T
+1.05%
MG-T
-1.41%
FR-T
+4.36%
Search stocks, ETFs and Commodities
Instrument Name
Generation Bio Co.
Instrument Symbol
(GBIO-Q)
Instrument Exchange
NASDAQ
Add to Watchlist
Create Alerts
USD
Today's Change
Real-Time
Last Update
Last Sale
Cboe BZX Real-Time
USD
Pre Market
Change
Pre Market
Last Update
Pre Market
Price
Volume
Summary
Charts
Profile
Financials
Statistics
Dividends
Price History
Analyst Estimates
Insiders
Generation Bio Co.
301 BINNEY STREET
CAMBRIDGE MA 02142 USA
P:
617-655-7500
http://www.generationbio.com
Sectors & Indices
Sector
Industry
Employees
SIC-2834 Pharmaceutical Preparations
Medical - Generic Drugs
Indices Russell 2000
Indices Russell 3000
Profile
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
Key Executives
Name
Title
Geoffrey McDonough
CEO/Director/President
Matthew Stanton
Chief Scientific Officer
Matthew Norkunas
CFO/Chief Accounting Officer
Yalonda Howze
Chief Legal Officer/Secretary
Antionette Paone
COO
Phillip Samayoa
Chief Strategy Officer
More from The Globe
opinion
Here’s the real reason your Canadian stocks can’t keep up
Tim Shufelt
4 hours ago
At the open: Getting a commodities boost, TSX hovers near record levels
5 hours ago
number cruncher
U.S technology stocks with earnings and price momentum
Yesterday
Lightspeed Commerce stock soars on better-than-expected profit forecast
Yesterday
GameStop, AMC dive further as meme stocks rally tapers off
Yesterday
The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
Yesterday
Proxy advisers recommend investors vote ‘no’ on Shopify executive pay
May 15, 2024
The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets
May 15, 2024